London, 15 November: Frazier & Deeter (FD) and GTM Global (GTM) announce a smarter way for ambitious UK EU bioscience, smart healthcare and med-tech businesses to enter the USA!
This new programme, launched from London on 5 December, will provide critical support for life sciences scale-ups, empowering them to achieve greater success in the US and globally by providing a virtual roadmap and curated 1-2-1 solutions to meet their go-to-market needs.
FDA, Regulatory Approvals & Operations
Getting FDA approval, setting up a US operation and finding the right local partners for your healthcare product or health-tech platform is risky, complex and time-consuming.
Interested founders will now be able to connect from their office chairs with regulatory experts, commercial partners, funders, economic development boards, universities and accelerator programmes, thus optimising qualified leads and making subsequent US business travel count!
Unique Ecosystem
With a presence in both the UK and the US, FD can provide unparalleled seamless services “across the pond,” supporting companies at every stage of growth.
Meanwhile, GTM’s unique ecosystem of government, trade and selected commercial partners delivers a holistic and collaborative approach to support life sciences scale-ups on their growth and internationalisation journeys.
FD and GTM have already established substantial interest from 500+ UK and EU life sciences companies in expanding to the US and will both continue to grow this sector as well as develop programmes for net-zero, smart infrastructure, aerospace and defence. For more information on a checklist of critical insights on Expanding into the US from FD, please click here.
Forthcoming events
Check out upcoming events here.
